![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 1315097.36 | 1408577.44 | 1289749.9 | |
Gross Profit | 328822.42 | 361258.96 | 313532.52 | |
Operating Income | 53953.07 | 40786.47 | ||
Net Income | 7212.99 | -3215.84 | -4397.52 | 13529.59 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 4315883.11 | 4291956.61 | 4167805.64 | |
Total Liabilities | 2733731.01 | 2664346 | 2552860.89 | |
Total Equity | 1582152.11 | 1627610.6 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 47736.41 | 68247.63 | 81955.19 | |
Cash From Investing Activities | -52920.61 | -53854.9 | -123121.1 | |
Cash From Financing Activities | 64427.17 | -7406.58 | ||
Net Change in Cash | 63055.3 | 61640.68 | -49877.82 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review